Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ resapp health limited

I think your point 1 will most likely happen.It's in there...

First 249 Last

Share
Profile

Follow
Jezza59

576 Posts.

73

26/05/22

04:02

Post #: 61625286
Share

Originally posted by delivercn: ↑

Thought about how the conflict of T/O is caused from below reality

*BOD - Very tired, running out of their wits to commercialize RAP, desperately want to sell out, they need everyone validate their past achievements

*Investors - Very confused, concerned about company potential and our investment more than handling to anybody else at cheap price

Problem: Company Policy makers are not supported by majority of investors while chance and risk are both huge at present

Possible solutions:
1 Sell out at a price most investors can accept, this will require BOD work harder for a much higher offer, the reward is they can offload happily
2 BOD partially shuffled to get momentum back for better commercialization, this will somehow discourage team as they have worked many years within their scope of knowledge
3 BOD completely changed so better policy can be made to represent investors interest, but they will fight back as this is not validating their past work

It is likely current BOD will keep running RAP if Pfizer walk away from the offer failure, which is not a good result at all. The conflict gap has been at its greatest since Covid test results published. Guys, time for a change, we just have to give them a big thank you and welcome someone more passionate and professional to step up RAP for us. All IMO

Expand

I think your point 1 will most likely happen.

It's in there interest it gets this through share options etc

There will be likely a premuim hopefully its above 25 cents most likely investors will except that because I think it's safe to say we have lost confidence in Management and BOD just my imo

RAP Price at posting: 11.3¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

End of FY is a time to juggle wins, losses and capital gains taxes

Time for retail therapy buying in the shopping Scentre for hot stocks

Eurozone-based companies find new ways to secure a regional lithium supply

SS1

Sun Silver submits US$60M Silver Paste Funding Application to US DoE